Amel Tounsi
Chief Executive Officer en Bridge2Health SA .
Origen de la red de primer grado Amel Tounsi.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Noshaq SA
 Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege.
33
| Private Company | Investment Managers | 33 |
Université Catholique de Louvain
31
| College/University | Other Consumer Services | 31 |
| Public Company | Pharmaceuticals: Major | 16 | |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Bridge2Health SA
 Bridge2Health SA BiotechnologyHealth Technology Bridge2Health SA provides biomedical translational research services. It offers services to the clinicians, basic researchers and pharmaceutical industries. The firm also provides blueprint for biobank query and retrieval between universities. The company was founded in September 2012 and is headquartered in Liege, Belgium.
6
| Holding Company | Biotechnology | 6 |
Amyl Therapeutics SRL
 Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation.
4
| Holding Company | Biotechnology | 4 |
MaSTherCell SA
 MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium.
1
| Subsidiary | Biotechnology | 1 |
Cerhum SA
 Cerhum SA Medical SpecialtiesHealth Technology Cerhum SA engages in the manufacture of dental equipment and supplies. Its products include MyBone and technical ceramics. It offers bone graft and dental printing, ceramic and plastic prototyping, small series production, three dimensional scanning services. The company was founded by Grégory Nolens and Caroline Remacle in 2015 and is headquartered in Liege, Belgium.
1
| Holding Company | Medical Specialties | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Amel Tounsi a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Maastricht University | College/University | Undergraduate Degree Masters Business Admin | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Graduate Degree Graduate Degree | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| Université Libre de Bruxelles | College/University | Graduate Degree Doctorate Degree | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree | |
| Vlerick Leuven Gent Management School | College/University | Graduate Degree Masters Business Admin | |
| ICHEC | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| University of Liege | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree | |
| DMS IMAGING | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
KitoZyme NV
 KitoZyme NV Miscellaneous Commercial ServicesCommercial Services KitoZyme SA manufactures biopolymers and provides medical device products. It develops and produces chitosan (and derivatives), chitin-glucan and beta-glucan, exclusively extracted from renewable, non-GMO vegetable sources. The firm specializes in weight management, digestive health and cardiovascular health products. The company was founded in December 2000 and is headquartered in Herstal, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Okairos AG
 Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Société d'Intégration par Le Travail en Environnement en
 Société d'Intégration par Le Travail en Environnement en Environmental ServicesIndustrial Services Société d'Intégration par Le Travail en Environnement en provides waste treatment services. It offers waste treatment services in the region of Liège. The firm collects bottles, flasks, plastic materials, metallic waste, and cartons for recycling. The company was founded in April 26, 1999 and is headquartered in Herstal, Belgium. | Environmental Services | Director/Board Member Director/Board Member | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Doctorate Degree | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal | |
Les Ateliers de la Meuse SA
 Les Ateliers de la Meuse SA Engineering & ConstructionIndustrial Services Les Ateliers de la Meuse SA provides mechanical maintenance services. Its products and services include machining of turbine components, maintenance of turbines, rotors and fixed parts, boiler works, scientific equipment for ground based and space experiments, and collin foundry equipment. The company was founded in 1850 and is headquartered in Sclessin, Belgium. | Engineering & Construction | Director/Board Member Director/Board Member Director/Board Member | |
Union Wallonne des Entreprises
 Union Wallonne des Entreprises Miscellaneous Commercial ServicesCommercial Services Union Wallonne des Entreprises (UWE) is an organization of private employers that aims to accelerate the creation and development of economic activity in historic Wallonia. UWE is based in Wavre, Belgium. UWE comprises thematic commissions, sectoral federations, and associated member companies. The organization provides an extranet for its members, publishes an agenda, and releases position papers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
BioWin ASBL
 BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Uteron Pharma SA
 Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Equipment/Instruments | Director/Board Member Founder Director/Board Member Director/Board Member | |
Sofina SA (Private Equity)
 Sofina SA (Private Equity) Investment ManagersFinance Sofina SA /Private Equity/ (Sofina) is a private equity firm founded in 1956. The firm is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
| Solvay Business School of Economics & Management | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
| ABIVAX | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer Director/Board Member | |
Le Pôle Image de Liège SA
 Le Pôle Image de Liège SA Miscellaneous Commercial ServicesCommercial Services Le Pôle Image de Liège SA provides a tax shelter facility for audiovisual service providers. The company was founded in 2006 and is headquartered in Liège, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Cide-Socran Asbl | Director/Board Member Director/Board Member Founder Consultant / Advisor | ||
Novalon SA
 Novalon SA Pharmaceuticals: MajorHealth Technology Novalon SA manufactures pharmaceutical products. It focuses on the development of therapeutically equivalent generic products that are complex to develop and manufacture. The firm develops the projects Zoreline and Myring, which are therapeutic equivalents to branded products. The company is headquartered in Liege, Belgium. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
LeanSquare
 LeanSquare Investment ManagersFinance LeanSquare provides business incubator services to start-ups. It coaches and finances to startups projects. The firm also offers advisory services. The company was founded on November 5, 2013 and is headquartered in Liege, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor Chief Operating Officer | |
Odyssea Pharma SRL
 Odyssea Pharma SRL Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Odyssea Pharma SPRL is a pharmaceutical development and Belgian production company. The private company is based in Grâce-Hollogne, Belgium. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Accessia Pharma SA
 Accessia Pharma SA Finance/Rental/LeasingFinance Accessia Pharma SA is a Belgian company that focuses on manufacturing products according to the needs of their clients. The company is based in Herstal, Belgium. The company provides tools and resources to help their clients benefit from economies of scale. Benjamin Boinem has been the CEO of the company since 2015. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Université Saint-Louis - Bruxelles ASBL | College/University | Undergraduate Degree Undergraduate Degree | |
AuXin Surgery SA
 AuXin Surgery SA Medical SpecialtiesHealth Technology AuXin Surgery SA develops, manufactures, and supplies combined medical devices for non-invasive surgery. The private company is based in Ottignies-Louvain-la-Neuve, Belgium. The Belgian company was founded in 2014 by Philippe Capart, Cecile Capart, Herve Capart, Carlo Zini, and Gilles Capart. The CEO is Benoît Verjans. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
TheClubDeal Capital Advisors SA (Private Equity)
 TheClubDeal Capital Advisors SA (Private Equity) Investment ManagersFinance TheClubDeal Capital Advisors SA (Private Equity) is a private equity/venture capital division of TheClubDeal Capital Advisors SA founded in 2016 by Nicolas de Moreau and Jean-Marc Legrand. The firm headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
Innovation Fund (BE)
 Innovation Fund (BE) Investment ManagersFinance Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
EyeD Pharma SA
 EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Medical Specialties | Founder Director/Board Member Director/Board Member | |
PDC Line Pharma SA
 PDC Line Pharma SA Pharmaceuticals: MajorHealth Technology Part of PDC Line Pharma SASU, PDC Line Pharma is a Belgian company that focuses on medical needs, particularly on skin cancer, which is the most lethal form of cancer worldwide. The private company is based in Liege, Belgium, and has two drug candidates in its pipeline, one for melanoma and another for lung cancer. The company aims to address this issue by developing drug candidates that can bring positive results to patients. PDC Line Pharma was founded in 2016 by Laurent Levy and Joel Plumas, and its CEO is Eric Halioua. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Founder Founder | |
| HYLORIS PHARMACEUTICALS SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Eklo Asbl
 Eklo Asbl Internet Software/ServicesTechnology Services Eklo Asbl operates as an innovative platform. The private company is based in Liege, Belgium. The Belgian company was founded by Marc Foidart. | Internet Software/Services | Founder Chief Executive Officer | |
| Hec Liège Management School | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Brasseries de Liege NV
 Brasseries de Liege NV Hotels/Resorts/Cruise linesConsumer Services Brasseries de Liege NV is a craft brewery located in the heart of the Cité Ardente in Liege, Belgium. The Belgian company produces the LEGIA beer range and cater to beer lovers. The company's description also mentions an opportunity to make good pancakes. | Hotels/Resorts/Cruise lines | Director/Board Member Director/Board Member | |
Odix SA
 Odix SA Packaged SoftwareTechnology Services Odix SA is a Belgian cybersecurity company that specializes in developing and marketing advanced anti-malware tools for enterprises of all sizes. The company is based in Thimister-Clermont, Belgium and was founded in 2020. The company's patented content disarm and reconstruction (TrueCDR™) technology is trusted by companies in various sectors, including industrial, finance, insurance, and government. The CEO is Valérie Gordenne. | Packaged Software | Chief Executive Officer Director/Board Member |
Estadísticas
Internacional
| Bélgica | 41 |
| Estados Unidos | 5 |
| Francia | 4 |
| Países Bajos | 3 |
| Suiza | 2 |
Sectorial
| Health Technology | 20 |
| Consumer Services | 14 |
| Commercial Services | 8 |
| Finance | 6 |
| Industrial Services | 3 |
Operativa
| Director/Board Member | 384 |
| Corporate Officer/Principal | 93 |
| Chief Executive Officer | 73 |
| Graduate Degree | 60 |
| Private Equity Investor | 51 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Marc Foidart | 38 |
| François Fontaine | 34 |
| Jean-Paul Prieels | 32 |
| François Fornieri | 28 |
| Florent Gros | 28 |
| David Solomon | 22 |
| Jean-Pascal Duvieusart | 19 |
| Ajit Shetty | 19 |
| Christian Moretti | 18 |
| Gaëtan Servais | 17 |
| Michèle Detaille | 17 |
| Jacques Galloy | 17 |
| Alain Herrera | 17 |
| Giulia van Waeyenberge | 16 |
| Leon van Rompay | 14 |
- Bolsa de valores
- Insiders
- Amel Tounsi
- Conexiones Empresas
